Breakthrough Cancer Research Secure €115k in Funding to Tackle Cancer Inequalities Cancer Charity Announces Partnership with Royal London Ireland

Breakthrough Cancer Research, a cancer-focused medical research charity has announced a new €115k charity partnership with Royal London Ireland, one of the leading life insurance and pensions companies in Ireland, to tackle inequalities that exist in the survival rates of some cancers.¹ Through advances in awareness, screenings and research innovations, the 5-year survival rates for cancers like breast and prostate cancer are over 88% according to the National Cancer Registry Ireland.² However, other cancers like pancreatic, oesophageal, lung, liver, ovarian, stomach and brain cancers have not seen the same levels of investment or subsequent survival rates, and some of these cancers currently have a 5-year survival rate as low as just 14%.²

The partnership will primarily fund research projects in the Breakthrough Cancer Research innovation fund, which focus on the cancers that have the lowest survival rates in Ireland. It will also fund the creation of evidence-based subject matter, training and resources to create more awareness, break down barriers around health education and dispel some of the myths surrounding cancer.